|
🐜
|
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
39 auth.
P. Ott,
S. Hu-Lieskovan,
B. Chmielowski,
R. Govindan,
A. Naing,
N. Bhardwaj,
K. Margolin,
M. Awad,
M. Hellmann,
Jessica J. Lin,
T. Friedlander,
M. Bushway,
Kristen N Balogh,
Tracey E. Sciuto,
Victoria L. Kohler,
...
S. Turnbull,
Rana H. Besada,
Riley R. Curran,
Benjamin Trapp,
J. Scherer,
A. Poran,
D. Harjanto,
D. Barthelme,
Ying S. Ting,
Jesse Z. Dong,
Yvonne Ware,
Yuting Huang,
Zhengping Huang,
Amy Wanamaker,
Lisa D. Cleary,
M. A. Moles,
K. Manson,
J. Greshock,
Z. Khondker,
E. Fritsch,
Michael S. Rooney,
M. DeMario,
R. Gaynor,
L. Srinivasan
|
8 |
2020 |
8
🐜
|
|
🦁
|
Targeting ALK: Precision Medicine Takes on Drug Resistance.
Jessica J. Lin,
Gregory Riely,
A. Shaw
|
8 |
2017 |
8
🦁
|
|
🐜
|
Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.
27 auth.
Z. Piotrowska,
H. Isozaki,
Jochen K. Lennerz,
J. Gainor,
Inga T. Lennes,
V. Zhu,
N. Marcoux,
M. Banwait,
S. Digumarthy,
Wenjia Su,
S. Yoda,
Amanda K. Riley,
Varuna Nangia,
Jessica J. Lin,
R. Nagy,
...
R. Lanman,
D. Dias-Santagata,
M. Mino‐Kenudson,
A. Iafrate,
R. Heist,
A. Shaw,
Erica K. Evans,
C. Clifford,
Sai-Hong Ignatius Ou,
B. Wolf,
A. Hata,
L. Sequist
|
8 |
2018 |
8
🐜
|
|
🐜
|
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.
22 auth.
A. Drilon,
Sai-Hong Ignatius Ou,
Byoung Chul Cho,
Dong-Wan Kim,
Jeeyun Lee,
Jessica J. Lin,
V. Zhu,
M. Ahn,
D. Camidge,
Judy Nguyen,
...
D. Zhai,
W. Deng,
Zhongdong Huang,
E. Rogers,
Juliet Liu,
J. Whitten,
John K Lim,
S. Stopatschinskaja,
David M. Hyman,
R. Doebele,
J. Cui,
A. Shaw
|
8 |
2018 |
8
🐜
|
|
🦁
|
Five‐Year Survival in EGFR‐Mutant Metastatic Lung Adenocarcinoma Treated with EGFR‐TKIs
7 auth.
Jessica J. Lin,
Stephanie Cardarella,
C. Lydon,
S. Dahlberg,
D. Jackman,
P. Jänne,
...
B. Johnson
|
8 |
2016 |
8
🦁
|
|
🐢
|
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
Alissa J Cooper,
L. Sequist,
Jessica J. Lin
|
8 |
2022 |
8
🐢
|
|
🦁
|
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.
21 auth.
Jessica J. Lin,
V. Zhu,
S. Yoda,
B. Yeap,
A. Schrock,
I. Dagogo-Jack,
Nicholas A. Jessop,
G. Jiang,
L. Le,
Kyle Gowen,
...
P. Stephens,
J. Ross,
Siraj M. Ali,
V. Miller,
M. Johnson,
C. Lovly,
A. Hata,
J. Gainor,
A. Iafrate,
A. Shaw,
S. Ou
|
7 |
2018 |
7
🦁
|
|
🐜
|
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.
27 auth.
S. Yoda,
Jessica J. Lin,
Michael S. Lawrence,
Michael S. Lawrence,
B. Burke,
L. Friboulet,
Adam Langenbucher,
Adam Langenbucher,
L. Dardaei,
Kylie Prutisto-Chang,
I. Dagogo-Jack,
Sergei L. Timofeevski,
H. Hubbeling,
J. Gainor,
Lorin A. Ferris,
...
Amanda K. Riley,
Krystina E. Kattermann,
Daria Timonina,
R. Heist,
A. Iafrate,
C. Benes,
J. Lennerz,
M. Mino‐Kenudson,
J. Engelman,
T. Johnson,
A. Hata,
A. Shaw
|
7 |
2018 |
7
🐜
|
|
🐜
|
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer.
21 auth.
J. Gainor,
D. Tseng,
S. Yoda,
I. Dagogo-Jack,
L. Friboulet,
Jessica J. Lin,
H. Hubbeling,
L. Dardaei,
A. Farago,
R. Katherine,
...
Schultz,
Lorin A. Ferris,
Z. Piotrowska,
J. Hardwick,
Donghui Huang,
Mari,
Mino-Kenudson,
A. Iafrate,
A. Hata,
B. Yeap,
A. Shaw
|
7 |
2017 |
7
🐜
|
|
🐜
|
Clinical acquired resistance to KRASG12C inhibition through a novel KRAS switch-II pocket mutation and polyclonal alterations converging on RAS-MAPK reactivation.
20 auth.
Noritaka Tanaka,
Jessica J. Lin,
Chendi Li,
Meagan B. Ryan,
Junbing Zhang,
L. Kiedrowski,
Alexa G Michel,
Mohammed U Syed,
Katerina A Fella,
Mustafa Sakhi,
...
I. Baiev,
D. Juric,
J. Gainor,
S. Klempner,
J. Lennerz,
G. Siravegna,
L. Bar-Peled,
A. Hata,
R. Heist,
R. Corcoran
|
7 |
2021 |
7
🐜
|
|
🦁
|
Recent Advances in Targeting ROS1 in Lung Cancer
Jessica J. Lin,
A. Shaw
|
7 |
2017 |
7
🦁
|
